Clinic
Roseville Urgent Care, PC
Roseville Urgent Care, PC was paid $6.52M by Medicaid between Jan 2018 and Dec 2024, across 62 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 39% of everything it billed.
33Billing provider infoROSEVILLE URGENT CARE, PC
ROSEVILLE, MI 48066
ROSEVILLE, MI 48066
33aNPI1811297070assigned 10/21/2010
33bProvider typeUrgent Care Clinic/Center
28Total paid$6.52M
24GClaims218,351
24DCodes billed62
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urgent Care Clinic/Center providers in Michigan
Rank by total paid#6 of 239
Median peer was paid$346K
This provider vs. median19×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 26,502 | $715K | |
| 2019 | 25,543 | $744K | |
| 2020 | 18,324 | $547K | |
| 2021 | 33,603 | $1.11M | |
| 2022 | 40,429 | $1.15M | |
| 2023 | 38,981 | $1.16M | |
| 2024incomplete | 34,969 | $1.10M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 39% | 48,383 | 43,267 | $2.51M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 25% | 25,247 | 22,202 | $1.65M |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 13% | 13,881 | 13,565 | $867K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 6.2% | 17,102 | 15,918 | $406K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.8% | 1,994 | 1,952 | $183K |
| 99058 | 2.6% | 3,261 | 2,377 | $171K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.3% | 14,225 | 7,457 | $152K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.8% | 3,321 | 3,105 | $119K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.7% | 11,385 | 10,844 | $109K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.1% | 10,336 | 9,155 | $70K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 1,314 | 1,313 | $65K |
| 81025 | <1% | 9,189 | 8,656 | $43K |
50 more codes
| 99000 | <1% | 15,557 | $33K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,519 | $29K |
| 81002 | <1% | 12,230 | $23K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 3,106 | $16K |
| 73130 | <1% | 959 | $13K | |
| 73630 | <1% | 885 | $12K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,610 | $8K |
| 73610 | <1% | 441 | $6K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,695 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 117 | $4K |
| 87807 | <1% | 422 | $3K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 103 | $3K |
| 99001 | <1% | 826 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 27 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 903 | $2K |
| 99406 | <1% | 363 | $2K | |
| 16020 | <1% | 43 | $2K | |
| 73110 | <1% | 70 | $1K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,846 | $1K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 327 | $1K |
| 99459 | <1% | 79 | $932.32 | |
| 69210 | <1% | 30 | $526.87 | |
| 82962 | <1% | 247 | $447.20 | |
| 97760 | <1% | 15 | $399.42 | |
| 73030 | <1% | 24 | $387.60 | |
| 93000 | <1% | 63 | $386.21 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 43 | $342.38 |
| 73562 | <1% | 26 | $303.94 | |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 2,188 | $224.18 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 72 | $206.88 |
| 74241 | <1% | 14 | $204.10 | |
| 86328 | <1% | 15 | $179.84 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 271 | $144.72 |
| 99407 | <1% | 14 | $78.25 | |
| S9083 | Global fee urgent care centers | <1% | 104 | $65.00 |
| 86308 | <1% | 36 | $63.65 | |
| 72100 | <1% | 15 | $57.06 | |
| 81005 | <1% | 55 | $46.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 46 | $43.08 |
| 36410 | <1% | 683 | $38.49 | |
| 99051 | <1% | 148 | $25.52 | |
| A6451 | Moderate compression bandage, elastic, knitted/woven, load resistance of 1.25 to 1.34 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard | <1% | 167 | $13.11 |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 5,080 | $1.16 |
| 99072 | 0% | 366 | $0.00 | |
| G9498 | Antibiotic regimen prescribed | 0% | 114 | $0.00 |
| J7610 | Albuterol, inhalation solution, compounded product, administered through dme, concentrated form, 1 mg | 0% | 133 | $0.00 |
| H0033 | Oral medication administration, direct observation | 0% | 155 | $0.00 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 350 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 61 | $0.00 |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 0% | 50 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialHAMOUD, LENA (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Southfield City Urgent Care PC | Southfield, MI | $8.56M |
| Get Well Urgent Care Sterling Heights PLC | Sterling Heights, MI | $2.69M |
| Get Well Urgent Care Dearborn PLC | Dearborn, MI | $1.19M |
| Get Well Urgent Care Dearborn Heights PLC | Dearborn Heights, MI | $774K |
| Get Well Urgent Care Shelby PLC | Shelby Township, MI | $483K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.